GEXVal CTO Presents at Nagoya University Graduate School
wpmaster
株式会社GEXVal
2025年9月9日
GEXVal CTO Presents at Nagoya University on Drug Discovery Careers and AI Applications
GEXVal Inc. (President and CEO: Juran Kato, PhD; Location: Fujisawa, Kanagawa, Japan, hereinafter “GEXVal”) is pleased to announce that Chief Technology Officer Dr. Yusuke Nakayama presented at a seminar hosted by Nagoya University Graduate School of Pharmaceutical Sciences, delivering a lecture titled "Drug Discovery Career Paths through Bioinformatics: From Pharmaceutical Companies to Ventures, and AI Applications."
[Seminar Overview]
Dr. Yusuke Nakayama brings over 20 years of extensive practical experience spanning from major pharmaceutical companies to drug discovery ventures, with expertise across diverse fields including target identification, drug repurposing, system development, and open innovation. In this seminar, he shared insights on organizational characteristics and key considerations for career development, while also introducing the latest trends in AI applications in drug discovery and platform development cases utilizing large language models (LLMs).
**Presentation Details**
|
Title |
Drug Discovery Career Paths through Bioinformatics: |
|
Date |
September 2, 2025 (Tuesday) |
|
Venue |
Nagoya University Graduate School of Pharmaceutical Sciences |
[About Nagoya University]
Nagoya University, established in 1939, is a prestigious national research university in Japan with seven Nobel Prize winners associated with it. The Graduate School of Informatics integrates natural sciences, social sciences, and humanities to develop cutting-edge information science that contributes to an advanced information-oriented society. Ranked among the top 200 universities globally*, the university is renowned for its innovative research and international programs.
For more information, visit: https://en.nagoya-u.ac.jp
*Reference: QS Quacquarelli Symonds Limited, TopUniversities
URL (as of September 4, 2025): https://www.topuniversities.com/universities/nagoya-university
[About GEXVal]
GEXVal strives to create and develop innovative pharmaceuticals for unmet medical needs, ensuring Treatment Reaches the Unreached with focus on rare diseases and underserved medical conditions. By leveraging our proprietary AI-powered pharmacoinformatics technology, we illuminate paths to breakthrough therapies, identifying hidden potential in drug candidates to deliver life-changing medicines that bring new hope to patients and their families.
有关本事宜请咨询:
Head of Corporate Office
Atsushi Sugizaki
info@gexval.com
